New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases

Journal of Biological Chemistry

Volumn 289, Issue 46, 2014, Pages 31777-31791

  Guarino, Carla ^a,g   Legowska, Monika ^b   Epinette, Christophe ^a   Kellenberger, Christine ^c   Dallet Choisy, Sandrine ^a   Sienczyk, Marcin ^d   Gabant, Guillaume ^e   Cadene, Martine ^e   Zoidakis, Jérôme ^f   Vlahou, Antonia ^f   Wysocka, Magdalena ^b   Marchand Adam, Sylvain ^a   Jenne, Dieter E ^g   Lesner, Adam ^b   Gauthier, Francis ^a   Korkmaz, Brice ^a  

^a Université Franaois Rabelais   (France)

^b UNIVERSITY OF GDA SK   (Poland)

^c CNRS   (France)

^d WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^e CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^f BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^g German Center for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BODY FLUIDS; CELL DEATH; DISEASES; ENZYME ACTIVITY;

BIOLOGICAL FLUIDS; BIOLOGICAL SAMPLES; ENDOGENOUS INHIBITOR; INFLAMMATORY DISEASE; LOW MOLECULAR MASS; PEPTIDE SUBSTRATES; PHOSPHONATE ESTER; PROTEOLYTIC DEGRADATION;

DISEASE CONTROL;

AUTOANTIBODY; ELASTASE; LEUKOCYTE ELASTASE; MYELOBLASTIN; NEUTROPHIL PROTEINASE 3; PEPTIDYL DI(CHLOROPHENYL)PHOSPHONATE ESTER DERIVATIVE; PHOSPHONIC ACID ESTER; PROTEINASE; UNCLASSIFIED DRUG; ESTER; OLIGOPEPTIDE; PEPTIDE; PHOSPHONIC ACID DERIVATIVE; PROLINE; PROTEINASE INHIBITOR; SOLVENT;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BIOTINYLATION; BLADDER CANCER; CELL ACTIVATION; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CONFORMATION; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; GRANULOMATOSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG FUNCTION; LUNG SECRETION; MOLECULAR PROBE; MOLECULAR WEIGHT; NEUTROPHIL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN STRUCTURE; URINE; WEGENER GRANULOMATOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL LINE; CELL MEMBRANE; CHEMICAL MODEL; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; HYDROLYSIS; INSECT; MASS SPECTROMETRY; METABOLISM; MUTATION;

ANIMALS; APOPTOSIS; BIOTINYLATION; CELL LINE; CELL MEMBRANE; ESTERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROLYSIS; INFLAMMATION; INSECTS; MASS SPECTROMETRY; MODELS, CHEMICAL; MUTATION; MYELOBLASTIN; NEUTROPHIL ACTIVATION; NEUTROPHILS; OLIGOPEPTIDES; ORGANOPHOSPHONATES; PEPTIDES; PROLINE; PROTEASE INHIBITORS; SOLVENTS;

EID: 84911374663     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.591339     Document Type: Article

References (51)

1. Turk, B. (2006) Targeting proteases: successes, failures, and future prospects. Nat. Rev. Drug Discov. 5, 785-799
2. Korkmaz, B., Moreau, T., and Gauthier, F. (2008) Neutrophil elastase, proteinase 3, and cathepsin G: physicochemical properties, activity, and physiopathological functions. Biochimie 90, 227-242
3. Korkmaz, B., Horwitz, M. S., Jenne, D. E., and Gauthier, F. (2010) Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol. Rev. 62, 726-759
4. Owen, C. A. (2008) Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 3, 253-268
5. Jenne, D. E., Tschopp,J., Ludemann,J., Utecht, B., and Gross, W. L. (1990) Wegener's autoantigen decoded. Nature 346, 520
6. Kallenberg, C. G. (2008) Pathogenesis of PR3-ANCA associated vasculitis. J. Autoimmun. 30, 29-36
7. Csernok, E., and Gross, W. L. (2013) Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener's). Expert Rev. Clin. Immunol. 9, 641-648
8. Gabillet, J., Millet, A., Pederzoli-Ribeil, M., Tacnet-Delorme, P., Guillevin, L., Mouthon, L., Frachet, P., and Witko-Sarsat, V. (2012) Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation. J. Immunol. 189, 2574-2583
9. Witko-Sarsat, V., Cramer, E. M., Hieblot, C., Guichard, J., Nusbaum, P., Lopez, S., Lesavre, P., and Halbwachs-Mecarelli, L. (1999) Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94, 2487-2496
10. Halbwachs-Mecarelli, L., Bessou, G., Lesavre, P., Lopez, S., and WitkoSarsat, V. (1995) Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett. 374, 29-33
11. Schreiber, A., Busjahn, A., Luft, F. C., and Kettritz, R. (2003) Membrane expression of proteinase 3 is genetically determined.J. Am. Soc. Nephrol. 14,68-75
12. Korkmaz, B., Kellenberger, C., Viaud-Massuard, M. C., and Gauthier, F. (2013) Selective inhibitors of human neutrophil proteinase 3. Curr. Pharm. Des. 19, 966-976
13. Sieñczyk, M., and Oleksyszyn, T- (2009) Irreversible inhibition of serine proteases: design and in vivo activity of diaryl a-aminophosphonate derivatives. Curr. Med. Chem. 16,1673-1687
14. Grzywa, R., and Sienczyk, M. (2013) Phosphonic esters and their application of protease control. Curr. Pharm. Des. 19, 1154-1178
15. Boduszek, B., Brown, A. D., and Powers, T. C. (1994) a-Aminoalkylphosphonate di(chlorophenyl) esters as inhibitors of serine proteases. J. Enzyme Inhib. 8,147-158
16. Brown, C. M., Ray, M., Eroy-Reveles, A. A., Egea, P., Tajon, C., and Crailc, C. S. (2011) Peptide length and leaving-group sterics influence potency of peptide phosphonate protease inhibitors. Chem. Biol. 18, 48-57
17. Woodard, S. L., Jackson, D. S., Abuelyaman, A. S., Powers, J. C., Winkler, U., and Hudig, D. (1994) Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NIC-mediated cytotoxicity.J. Immunol. 153, 5016-5025
18. Schechter, I., and Berger, A. (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27,157-162
19. Jégot, G., Derache, C., Castella, S., Lahouassa, H., Pitois, E., Jourdan, M. L., Remold-O'Donnell, E., Kellenberger, C., Gauthier, F., and Korkmaz, B. (2011) A substrate-based approach to convert SerpinBl into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen. FASEB J 25, 3019-3031
20. Korkmaz, B., Hajjar, E., Kalupov, T., Reuter, N., Brillard-Bourdet, M., Moreau, T., Juliano, L., and Gauthier, F. (2007) Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase: a kinetic and molecular modeling analysis.J. Biol. Chem. 282, 1989-1997
21. Sieńczyk, M., and Oleksyszyn, J. (2006) Inhibition of trypsin and urokinase by Cbz-amino(4-guanidinophenyl)methanephosphonate aromatic ester derivatives: the influence of the ester group on their biological activity. Bioorg. Med. Chem. Lett. 16, 2886-2890
22. Oleksyszyn, J., and Powers, J. C. (1989) Irreversible inhibition of serine proteases by peptidyl derivatives of a-aminoalkylphosphonate diphenyl esters. Biochem. Biophys. Res. Commun. 161,143-149
23. Korkmaz, B., Attucci, S., Hazouard, E., F err an di ere, M., Jourdan, M. L., Brillard-Bourdet, M., Juliano, L., and Gauthier, F. (2002) Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.J. Biol. Chem. 277, 39074-39081
24. Tian, W. X., and Tsou, C. L. (1982) Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry 21,1028-1032
25. Korkmaz, B., Attucci, S., Juliano, M. A., Kalupov, T., Jourdan, M. L., Juliano, L., and Gauthier, F. (2008) Measuring elastase, proteinase 3, and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates. Nat. Protoc. 3, 991-1000
26. Fujinaga, M., Chernaia, M. M., Halenbeck, R., Koths, K., and James, M. N. (1996) The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.J. Mol. Biol. 261, 267-278
27. Korkmaz, B., Attucci, S., Moreau, T., Godat, E., Juliano, L., and Gauthier, F. (2004) Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am. J Respir. Cell Mol. Biol. 30, 801-807
28. Derache, C., Epinette, C., Roussel, A., G ab ant, G., Cadene, M., Korkmaz, B., Gauthier, F., and Kellenberger, C. (2012) Crystal structure of greglin, a novel non-classical Kazal inhibitor, in complex with subtilisin. FEBS J. 279,4466-4478
29. Zoidakis, J., Makridakis, M., Zerefos, P. G., Bitsika, V., Esteban, S., Frantzi, M., Stravodimos, K., Anagnou, N. P., Roubelakis, M. G., Sanchez-Carbayo, M., and Vlahou, A. (2012) Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol. Cell Proteomics 10.1074mcp.M111. 009449 1-15
30. Kasperkiewicz, P., Poreba, M., Snipas, S. J., Parker, H., Winterbourn, C. C., Salvesen, G. S., and Drag, M. (2014) Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling. Proc. Natl. Acad. Sci. U.S.A. 111, 2518-2523
31. Korkmaz, B., Jaillet, J., Jourdan, M. L., Gauthier, A., Gauthier, F., and Attucci, S. (2009) Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J. Biol. Chem. 284,19896-19902
32. Korkmaz, B., Lesner, A., Letast, S., Mahdi, Y. K., Jourdan, M. L., DalletChoisy, S., Marchand-Adam, S., Kellenberger, C., Viaud-Massuard, M. C., Jenne, D. E., and Gauthier, F. (2013) Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis). Semin. Immunopathol. 35, 411-421
33. Hajjar, E., Mihajlovic, M., Witko-Sarsat, V., Laz aridis, T., and Reuter, N. (2008) Computational prediction of the binding site of proteinase 3 to the plasma membrane. Proteins. 71, 1655-1669
34. Broemstrup, T., and Reuter, N. (2010) How does proteinase 3 interact with lipid bilayers? Phys. Chem. Chem. Phys. 12, 7487-7496
35. Korkmaz, B., Kuhl, A., Bayat, B., Santoso, S., and Jenne, D. E. (2008) A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors. J. Biol. Chem. 283, 35976-35982
36. Hajjar, E., Broemstrup, T., Kantari, C., Witko-Sarsat, V., and Reuter, N. (2010) Structures of human proteinase 3 and neutrophil elastase: so similar yet so different. FEBS J. 277, 2238-2254
37. Hajjar, E., Korkmaz, B., and Reuter, N. (2007) Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase. FEBS Lett. 581, 5685-5690
38. Sieńczyk, M., Podgórski, D., Bla¿ejewska, A., Kulbacka, J., Saczko, J., and Oleksyszyn, J. (2011) Phosphonic pseudopeptides as human neutrophil elastase inhibitors: a combinatorial approach. Bioorg. Med. Chem. 19, 1277-1284
39. Clark, J. M., Vaughan, D. W., Aiken, B. M., and Kagan, H. M. (1980) Elastase-like enzymes in human neutrophils localized by ultrastructural cytochemistry. J. Cell Biol. 84,102-119
40. Benson, K. F., Li, F. Q., Person, R. E., Albani, D., Duan, Z., Wechsler, J.,Meade-White, K., Williams, K., Acland, G. M., Niemeyer, G., Lothrop, C. D., and Horwitz, M. (2003) Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat. Genet. 35, 90-96
41. Köllner, I., Sodeik, B., Schreek, S., Heyn, H., von Neuhoff, N., Germeshausen, M., Zeidler, C., Krüger, M., Schlegelberger, B., Welte, K., and Beger, C. (2006) Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 108, 493-500
42. Csernok, E., Lüdemann, J., Gross, W. L., and Bainton, D. F. (1990) Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplas-mic antibodies circulating in Wegener's granulomatosis. Am. J. Pathol. 137,1113-1120
43. Tervaert, J. W., Mulder, L., Stegeman, C., Elema, J., Huitema, M., The, H., and Kallenberg, C. (1993) Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann. Rheum. Dis. 52,115-120
44. Kantari, C., Millet, A., Gabili et, J., Hajjar, E., Broemstrup, T., Pluta, P., Reuter, N., and Witko-Sarsat, V. (2011) Molecular analysis of the membrane insertion domain of proteinase 3, the Wegener's autoantigen, in RBL cells: implication for its pathogenic activity. J. Leukoc. Biol. 90, 941-950
45. Korkmaz, B., Jenne, D. E., and Gauthier, F. (2013) Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases. Int. Immunopharmacol. 17,1198-1205
46. Hinkofer, L. C., Seidel, S. A., Korkmaz, B., Silva, F., Hummel, A. M., Braun, D., Jenne, D.E., and Specks, U. (2013) A monoclonal antibody (MCPR3-7) interfering with the activity of proteinase 3 by an allosteric mechanism. J. Biol. Chem. 288, 26635-26648
47. Hink-Schauer, C., Estébanez-Perpiñá, E., Wilharm, E., Fuentes-Prior, P., Klinkert, W., Bode, W., and Jenne, D. E. (2002) The 2.2-A crystal structure of human pro-granzyme K reveals a rigid zymogen with unusual features. J. Biol. Chem. 277, 50923-50933
48. Korkmaz, B., Attucci, S., Jourdan, M. L., Juliano, L., and Gauthier, F. (2005) Inhibition of neutrophil elastase by αl-protease inhibitor at the surface of human polymorphonuclear neutrophils.J. Immunol. 175, 3329-3338
49. Bode, W., Wei, A. Z., Huber, R., Meyer, E., Travis, J., and Neumann, S. (1986) X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBOJ. 5, 2453-2458
50. Attucci, S., Gauthier, A., Korkmaz, B., Delépine, P., Martino, M. F., Saudubray, F., Diot, P., and Gauthier, F. (2006) EPI-hNE4, a proteolysisresistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis. J. Pharmacol. Exp. Ther. 318, 803-809
51. von Vietinghoff, S., Tunnemann, G., Eulenberg, C., Wellner, M., Cristina Cardoso, M., Luft, F. C., and Kettritz, R. (2007) NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood 109, 4487-4493